Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Taketo Kawai

Teikyo University School of Medicine

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

30%

Surgery

50%

Urology

80%

Oncology

60%

Urinary Tract

50%

Bladder Cancer

40%

Prostate Cancer

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles27

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

Article Link

Year:

2025

Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study

Article Link

Year:

2025

Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinoma

Article Link

Year:

2025

Local therapy for oligometastatic prostate cancer

Article Link

Year:

2025

The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study

Article Link

Year:

2025

Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma

Article Link

Year:

2025

Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis

Article Link

Year:

2025

Vesicovaginal fistula and bladder calculus formation secondary to long‐term retention of an intrauterine device

Article Link

Year:

2024

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer

Article Link

Year:

2024

Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study

Article Link

Year:

2024

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional study

Article Link

Year:

2024

Photodynamic diagnosis‐assisted transurethral resection of bladder tumor for high‐risk non‐muscle invasive bladder cancer improves intravesical recurrence‐free survival (BRIGHT study)

Article Link

Year:

2024

Is there a role for pembrolizumab beyond progression in urothelial carcinoma?

Article Link

Year:

2024

Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma

Article Link

Year:

2024

Lower pretreatment serum testosterone level predicts poor prognosis in the patients with metastatic hormone-sensitive prostate cancer undergoing androgen deprivation therapy

Article Link

Year:

2024

Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative review

Article Link

Year:

2024

Efficacy and safety of intravesical dimethyl sulfoxide treatment for patients with refractory Hunner‐type interstitial cystitis: Real‐world data postofficial approval in Japan

Article Link

Year:

2024

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab

Article Link

Year:

2023

Predictive Factors of Lower Urinary Tract Injuries and Spontaneous Voiding Failure After Pelvic Fractures.

Article Link

Year:

2023

Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients.

Article Link

Year:

2023

Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.

Article Link

Year:

2023

Deep Learning Models for Cystoscopic Recognition of Hunner Lesion in Interstitial Cystitis.

Article Link

Year:

2023

Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma.

Article Link

Year:

2022

Preservation of pelvic floor muscles contributes to early continence recovery after robot-assisted radical prostatectomy.

Article Link

Year:

2022

The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy.

Article Link

Year:

2022

Primary diffuse large B cell lymphoma of the prostate in a patient with HIV infection.

Article Link

Year:

2022

Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer.

Article Link

Year:

2022

Collaborators12

Tomoyuki Kaneko

Teikyo University

JAPAN

Kazuma Sugimoto

University of Tokyo Hospital

JAPAN

Sebastiano Buti

ITALY

Tohru Nakagawa

JAPAN

Yukari Uemura

Section Chief

National Center For Global Health and Medicine

JAPAN

Masaki Shiota

Kyushu University

JAPAN

Yusuke Sugino

Mie university

JAPAN

Kiyoaki Nishihara

Kurume University

JAPAN

Motofumi Suzuki

Chief director

JAPAN

Melissa Bersanelli

Adjunct Professor in Medical Oncology

University of Parma

ITALY

Hidenori Sakanashi

National Institute of Advanced Industrial Science and Technology (AIST)

JAPAN

Keita Kobayashi

Yamaguchi University

JAPAN

How do I reach out?

Meet Kite AI